SUMATRIPTAN SUCC 50 MG TABLET
For 30 tablets
Pharmacies pay
$9.07 filed
30 × $0.30222 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$15.43 estimated
$9.07 + $1.36 (15%) + $5.00 fee per fill = $15.43
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
SUMATRIPTAN SUCC 50 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “sumatriptan” and “sumatriptan succinate”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., NorthStar Rx LLC and Dr. Reddy's Laboratories Limited.
FDA’s Established Pharmacologic Class for it is Serotonin-1b and Serotonin-1d Receptor Agonist.
The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 12 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $9.07 for 30 tablets (30 × $0.30222 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 6 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Dr. Reddy's Laboratories Limited | 4 | $0.30222 per EA filed |
| Rising Pharma Holdings, Inc. | 3 | $0.30222 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.30222 per EA filed |
| Bionpharma Inc. | 1 | $0.30222 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.30222 per EA filed |
| NorthStar Rx LLC | 1 | $0.30222 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.30222 per EA filed |
When these prices took effect
- 2026-09-30 · 1 NDC · $0.30222 per EA filed
- 2026-09-23 · 12 NDCs · $0.30222 per EA filed
All 13 NDCs, with labeler and price
- 00378-5631-59 · Mylan Pharmaceuticals Inc. · $0.30222 per EA · eff. 2026-09-23 filed
- 16714-0797-01 · NorthStar Rx LLC · $0.30222 per EA · eff. 2026-09-23 filed
- 55111-0292-09 · Dr. Reddy's Laboratories Limited · $0.30222 per EA · eff. 2026-09-23 filed
- 55111-0292-36 · Dr. Reddy's Laboratories Limited · $0.30222 per EA · eff. 2026-09-23 filed
- 55111-0292-90 · Dr. Reddy's Laboratories Limited · $0.30222 per EA · eff. 2026-09-23 filed
- 55111-0292-98 · Dr. Reddy's Laboratories Limited · $0.30222 per EA · eff. 2026-09-23 filed
- 64980-0661-27 · Rising Pharma Holdings, Inc. · $0.30222 per EA · eff. 2026-09-23 filed
- 64980-0661-36 · Rising Pharma Holdings, Inc. · $0.30222 per EA · eff. 2026-09-23 filed
- 64980-0661-91 · Rising Pharma Holdings, Inc. · $0.30222 per EA · eff. 2026-09-23 filed
- 65862-0147-36 · Aurobindo Pharma Limited · $0.30222 per EA · eff. 2026-09-23 filed
- 65862-0147-59 · Aurobindo Pharma Limited · $0.30222 per EA · eff. 2026-09-30 filed
- 69452-0345-60 · not listed as a package in the FDA directory · $0.30222 per EA · eff. 2026-09-23 filed
- 69452-0345-72 · Bionpharma Inc. · $0.30222 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
12 other products in the NADAC file share an FDA nonproprietary name with SUMATRIPTAN SUCC 50 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| IMITREX 4 MG/0.5 ML PEN INJECT | $463.07333 per ML filed | We don’t know yet |
| IMITREX 6 MG/0.5 ML CARTRIDGES | $436.79714 per ML filed | We don’t know yet |
| IMITREX 6 MG/0.5 ML PEN INJECT | $460.05429 per ML filed | We don’t know yet |
| IMITREX 100 MG TABLET | $72.39673 per EA filed | We don’t know yet |
| SUMATRIPTAN 5 MG NASAL SPRAY | $17.03859 per EA filed | $21.97218 per EA filed |
| SUMATRIPTAN 6 MG/0.5 ML AUTOINJ | $61.41234 per ML filed | We don’t know yet |
| SUMATRIPTAN 6 MG/0.5 ML VIAL | $14.93447 to $15.00 per ML filed | We don’t know yet |
| SUMATRIPTAN 20 MG NASAL SPRAY | $16.5061 per EA filed | $21.97218 per EA filed |
| SUMATRIPTAN SUCC 25 MG TABLET | $0.23942 per EA filed | We don’t know yet |
| SUMATRIPTAN SUCC 50 MG TABLET this page | $0.30222 per EA filed | We don’t know yet |
| SUMATRIPTAN SUCC 100 MG TABLET | $0.43878 per EA filed | We don’t know yet |
| TOSYMRA 10 MG NASAL SPRAY | $108.22118 per EA filed | $107.19459 per EA filed |
| ZEMBRACE SYMTOUCH 3 MG/0.5 ML | $384.08921 per ML filed | $379.30264 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-07-22 and 2026-09-30 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 13 NDCs’ NADAC prices is $0.30222 per EA filed.
Of the 28 other products in FDA’s Serotonin-1b and Serotonin-1d Receptor Agonist class priced per EA, 27 have a higher middle NADAC price and 1 a lower one. The one in the middle is FROVATRIPTAN SUCC 2.5 MG TAB, at $2.71707 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- RIZATRIPTAN 10 MG TABLET
- NARATRIPTAN HCL 1 MG TABLET
- ELETRIPTAN HBR 20 MG TABLET
- ZOLMITRIPTAN 2.5 MG TABLET
- FROVATRIPTAN SUCC 2.5 MG TAB